Drug maker AstraZeneca (AZN) announced the full results of Phase III FLAURA trial, which support TAGRISSO's clear potential as a new standard of care (SoC) in the 1st-line treatment of adult patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung...

Genentech, a member of the Roche Group (RHHBY), said that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application or sBLA and granted Priority Review for Gazyva or obinutuzumab in combination with chemotherapy followed by Gazyva alone for people with...

JNJ-lawsuit-082117.jpg Johnson & Johnson (JNJ) has been ordered to pay $417 million to a woman who claims to have developed ovarian cancer after using the company's talc products for feminine hygiene. The Los Angeles Superior Court jury passed the verdict in favor of California resident Eva Echeverria. It is the largest...

Rolling-stones-062116.jpg Rolling Stones guitarist Ronnie Wood recently struggled to overcome what he called a "touch of lung cancer." The rock icon revealed his health scare with the Mail on Sunday, telling the U.K. paper that he had an operation to take out part of his lung.

Aug2017-072717.jpg We are well into the second half of 2017. Now, let's take a look at the biotech stocks awaiting word from the FDA in August.

Pharma-072117.jpg Today's Daily Dose lists the names of drugs that were recommended for approval by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on Friday. The lone exception is Vanda's antipsychotic medicine Fanaptum, for which the CHMP has rendered a negative opinion.

JohnMccain-072017.jpg Republican Senator and chairman of the Senate Armed Services Committee John McCain, R-Ariz., has been diagnosed with glioblastoma - a very aggressive brain cancer. The tumor was discovered during surgery to remove a blood clot from above McCain's left eye last week. On July 14th, McCain underwent...

Dignicap-FDA-120915.jpg Nearly one and a half years after securing FDA clearance for use in breast cancer patients to reduce the severity of chemotherapy-induced hair loss, DigniCap scalp cooling system has scored yet another regulatory nod.

Oliveoil-060617.jpg Much has been written about the benefits of olive oil, which forms a part and parcel of Mediterranean diet.

Colorectal cancer rates amongst adults under the age of 50 are on the rise, according to a recent study. Cases of colon and rectal cancer are on the rise in people under 50, according to the recent study, which showed that rates increased by more than 11 percent between 2004 and 2014. African-Americans are about twice as likely as whites to be diagnosed before the age of 50.

smoking-112116.jpg Smoking cigarettes may lead to the decrease in the effectiveness of certain kidney disease drugs, a new study suggests. The study, presented at an American Society of Nephrology conference, tracked 108 smokers and 108 nonsmokers who were also taking angiotensin-converting enzyme inhibitors (blood pressure lowering medicine) for early chronic kidney diseases.

TheSun-110916.jpg A new study that was presented at the annual meeting of the Society for Endocrinology, in Brighton, England, finds that low levels of vitamin D may increase the risk of bladder cancer. Researchers found that cells that line the bladder activate and respond to vitamin D. The importance of this is that it stimulates an immune response.

Hookah-110916.jpg A recent study in Dubai has attempted to put to test some misconceptions associated with smoking hookah. A study reported in the journal Tobacco Control says that smoking a hookah indoors is more dangerous than smoking cigarettes. Dr. Michael Weitzman, a professor at New York University School of Medicine says, "There are widespread misconceptions that hookah is a safer alternative . . ."

E-Cigarette-110916.jpg A new study shows that teens who "vape" e-cigarettes are more likely to move on to regular cigarettes. The survey was conducted over ten Los Angeles county schools. The study was published November 8 in the Journal of American Medical Association. Leading researcher Adam Leventhal cited that, "teens who vape frequently are more than twice as likely to start smoking on about a weekly basis."

A new study suggests that the use of smokeless tobacco, or snus, may increase the risk of death in those with prostate cancer. The study, published in the International Journal of Cancer, found that those who used snus but did not smoke were three times more likely to die from prostate cancer than those who never used tobacco. For the study, researchers analyzed health check-up data.

Follow RTT